A global perspective of the epidemiology and burden of Varicella-Zoster Virus

Current Pediatric Reviews

Volumn 5, Issue 4, 2009, Pages 207-228

  Sengupta, Nitu ^a   Breuer, Judy ^b  

^a Tower Hamlets Community Health Services ^*  (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; RAIN; VARICELLA ZOSTER VACCINE;

AFRICA; AGE DISTRIBUTION; ARTICLE; ASIA; AUSTRALIA; CELLULAR IMMUNITY; CHICKENPOX; CHILDHOOD MORTALITY; CLINICAL TRIAL; ENVIRONMENTAL TEMPERATURE; EPIDEMIC; EUROPE; GROUPS BY AGE; HEALTH DISPARITY; HERPES ZOSTER; HIGH RISK POPULATION; HUMAN; HUMIDITY; INDIA; INFECTION RISK; INJURY; MIDDLE EAST; MOLECULAR EPIDEMIOLOGY; MORBIDITY; NORTH AMERICA; POPULATION DYNAMICS; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RACE DIFFERENCE; REINFECTION; SEASONAL VARIATION; SEROPREVALENCE; SEX DIFFERENCE; SOUTH AMERICA; SOUTHERN EUROPE; TROPIC CLIMATE; URBAN RURAL DIFFERENCE; VACCINATION; VARICELLA ZOSTER VIRUS; VIRUS STRAIN; VIRUS TRANSMISSION;

EID: 77954337306     PISSN: 15733963     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339609791317315     Document Type: Article

References (260)

1. Gershon AA, Raker R, Steinberg S, Topf-Olstein B, Drusin LM.Antibody to Varicella-Zoster virus in parturient women and theiroffspring during the first year of life. Pediatrics 1976; 58(5): 692-6.
2. Poulsen A, Cabral F, Nielsen J, et al. Varicella zoster in Guinea-Bissau: intensity of exposure and severity of infection. PediatrInfect Dis J 2005; 24(2): 102-7.
3. Izurieta HS, Strebel PM, Blake PA. Postlicensure effectiveness ofvaricella vaccine during an outbreak in a child care center. JAMA1997 12; 278(18): 1495-9.
4. Clements DA, Moreira SP, Coplan PM, Bland CL, Walter EB.Postlicensure study of varicella vaccine effectiveness in a day-caresetting. Pediatr Infect Dis J 1999; 18(12): 1047-50.
5. Buchholz U, Moolenaar R, Peterson C, Mascola L. Varicellaoutbreaks after vaccine licensure: should they make you chicken?Pediatrics 1999; 104(3 Pt 1): 561-3.
6. Galil K, Brown C, Lin F, Seward J. Hospitalizations for varicella inthe United States, 1988 to 1999. Pediatr Infect Dis J 2002 Oct;21(10): 931-5.
7. Galil K, Fair E, Mountcastle N, Britz P, Seward J. Younger age atvaccination may increase risk of varicella vaccine failure. J InfectDis. 2002; 186(1): 102-5.
8. Galil K, Lee B, Strine T, et al. Outbreak of varicella at a day-carecenter despite vaccination. N Engl J Med 2002; 347(24): 1909-15.
9. Tugwell BD, Lee LE, Gillette H, Lorber EM, Hedberg K, CieslakPR. Chickenpox outbreak in a highly vaccinated school population.Pediatrics 2004; 113(3 Pt 1): 455-9.
10. Lee BR, Feaver SL, Miller CA, Hedberg CW, Ehresmann KR. Anelementary school outbreak of varicella attributed to vaccinefailure: policy implications. J Infect Dis 2004; 190(3): 477-83.
11. Haddad MB, Hill MB, Pavia AT, et al. Vaccine effectivenessduring a varicella outbreak among schoolchildren: Utah, 2002-2003. Pediatrics 2005; 115(6): 1488-93.
12. Hope-Simpson RE. The nature of herpes zoster: A long-term studyand a new hypothesis. Proc R Soc Med 1965; 58: 9-20.
13. Ross AH. Modification of chicken pox in family contacts byadministration of gamma globulin. New Eng J Med 1962; 267: 369-76.
14. Yorke JA, London WP. Recurrent outbreaks of measles,chickenpox and mumps II. Systematic differences in contact ratesand stochastic effects. Am J Epidemiol 1973; 98(6): 469-82.
15. London WP, Yorke JA. Recurrent outbreaks of measles,chickenpox and mumps. Seasonal variation in contact rates. Am JEpidemiol 1973; 98(6): 453-68.
16. Seward JF, Zhang JX, Maupin TJ, Mascola L, Jumaan AO.Contagiousness of varicella in vaccinated cases: A householdcontact study. JAMA 2004; 292(6): 704-8.
17. Balraj V, John TJ. An epidemic of varicella in rural southern India.J Trop Med Hyg 1994; 97(2): 113-6.
18. Sinha DP. Chickenpox--a disease predominantly affecting adults inrural West Bengal, India. Int J Epidemiol 1976; 5(4): 367-74.
19. Somekh E, Dalal I, Shohat T, Ginsberg GM, Romano O. Theburden of uncomplicated cases of chickenpox in Israel. J Infect 2002; 45(1): 54-7.
20. Dunkle LM, Arvin AM, Whitley RJ, et al. A controlled trial ofacyclovir for chickenpox in normal children. New Eng J Med 1991;325(22): 1539-44.
21. Poulsen A, Qureshi K, Lisse I, et al. A household study ofchickenpox in Guinea-Bissau: Intensity of exposure is adeterminant of severity. J Infect 2002; 45(4): 237-42.
22. Paul N, Jacob ME. An outbreak of cadaver-acquired chickenpox ina health care setting. Clin Infect Dis 2006; 43(5): 599-601.
23. Sengupta NW, Sie AH, Eleftheriou D, et al. Transmission dynamicsof chickenpox in the UK: A prospective multi centre study, inEuropean society of paediatric infectious diseases. Graz, Austria2008.
24. Ozaki T, Miwata H, Matsui Y, Kido S, Yamanishi K. Varicellazoster virus DNA in throat swabs. Arch Dis Child 1991; 66(3): 333-4.
25. Asano Y, Yoshikawa T, Ihira M, Furukawa H, Suzuki K, Suga S.Spread of varicella-zoster virus DNA to family members andenvironments from siblings with varicella in a household. Pediatrics1999; 103(5): e61.
26. Sawyer MH, Chamberlin CJWu YN, Aintablian N, Wallace MR.Detection of varicella-zoster virus DNA in air samples fromhospital rooms. J Infect Dis 1994; 169(1): 91-4.
27. Suzuki K, Yoshikawa T, Tomitaka A, Suzuki K, Matsunaga K,Asano Y. Detection of varicella-zoster virus DNA in throat swabsof patients with herpes zoster and on air purifier filters. J Med Virol2002; 66(4): 567-70.
28. Suzuki K, Yoshikawa T, Ihira M, Ohashi M, Suga S, Asano Y.Spread of varicella-zoster virus DNA to the environment fromvaricella patients who were treated with oral acyclovir. Pediatr Int2003; 45(4): 458-60.
29. Yoshikawa T, Ihira M, Suzuki K, et al. Rapid contamination of theenvironments with varicella-zoster virus DNA from a patient withherpes zoster. J Med Virol 2001; 63(1): 64-6.
30. Sawyer MH, Wu YN, Chamberlin CJ, et al. Detection of varicella-zoster virus DNA in the oropharynx and blood of patients withvaricella. J Infect Dis 1992; 166(4): 885-8.
31. Asano Y, Iwayama S, Miyata T, et al. Spread of varicella inhospitalized children having no direct contact with an indicatorzoster case and its prevention by a live vaccine. Biken J 1980;23(3): 157-61.
32. Josephson A, Gombert ME. Airborne transmission of nosocomialvaricella from localized zoster. J Infect Dis 1988; 158(1): 238-41.
33. Wreghitt TG, Whipp J, Redpath C, Hollingworth W. An analysis ofinfection control of varicella-zoster virus infections inAddenbrooke's Hospital Cambridge over a 5-year period, 1987-92.Epidemiol Infect 1996; 117(1): 165-71.
34. Brunell PA, Argaw T. Chickenpox attributable to a vaccine viruscontracted from a vaccinee with zoster. Pediatrics 2000; 106(2):E28.
35. Seiler HE. A study of herpes zoster particularly in its relationship tochickenpox. J Hygiene 1949; 47(3): 253-62.
36. Lopez AS, Burnett-Hartman A, Nambiar R, et al. Transmission of anewly characterized strain of varicella-zoster virus from a patientwith herpes zoster in a long-term-care facility, West Virginia, 2004.J Infect Dis 2008; 197(5): 646-53.
37. Mehta SK, Tyring SK, Gilden DH, et al. Varicella-zoster virus inthe saliva of patients with herpes zoster. J Infect Dis 2008; 197(5):654-7.
38. Mehta SK, Cohrs RJ, Forghani B, Zerbe G, Gilden DH, PiersonDL. Stress-induced subclinical reactivation of varicella zoster virusin astronauts. J Med Virol 2004; 72(1): 174-9.
39. Cohrs RJ, Mehta SK, Schmid DS, Gilden DH, Pierson DL.Asymptomatic reactivation and shed of infectious varicella zostervirus in astronauts. J Med Virol 2008; 80(6): 1116-22.
40. Joseph CA, Noah ND. Epidemiology of chickenpox in England andWales, 1967-85. Br Med J (Clin Res Ed) 1988; 296(6623): 673-6.
41. Preblud SR, D'Angelo LJ. Chickenpox in the United States, 1972-1977. J Infect Dis 1979; 140(2): 257-60.
42. Socan M, Blasko M. Surveillance of varicella and herpes zoster inSlovenia, 1996 - 2005. Euro Surveill 2007; 12(2).
43. Bramley JC, Jones IG. Epidemiology of chickenpox in Scotland:1981 to 1998. Commun Dis Public Health 2000; 3(4): 282-7.
44. Brisson M, Edmunds WJ, Law B, et al. Epidemiology of varicellazoster virus infection in Canada and the United Kingdom.Epidemiol Infect 2001; 127(2): 305-14.
45. Deguen S, Chau NP, Flahault A. Epidemiology of chickenpox inFrance (1991-1995). J Epidemiol Commun Health 1998; 52(Suppl1): 46S-9S.
46. Fornaro P, Gandini F, Marin M, et al. Epidemiology and costanalysis of varicella in Italy: Results of a sentinel study in thepediatric practice. Italian Sentinel Group on Pediatric InfectiousDiseases. Pediatr Infect Dis J 1999; 18(5): 414-9.
47. Perez-Farinos N, Ordobas M, Garcia-Fernandez C, et al. Varicellaand herpes zoster in Madrid, based on the sentinel generalpractitioner network: 1997-2004. BMC Infect Dis 2007; 7: 59.
48. Russell ML, Svenson LW, Yiannakoulias N, Schopflocher DP,Virani SN, Grimsrud K. The changing epidemiology of chickenpoxin Alberta. Vaccine 2005; 23(46-47): 5398-403.
49. Trlifajova J, Svandova E, Pokorny J, Pokorny J. A laboratory studyof age-related varicella incidence and prevalence in the CzechSocialist Republic. Acta Virol 1989; 33(2): 183-7.
50. Choo PW, Donahue JG, Manson JE, Platt R. The epidemiology ofvaricella and its complications. J Infect Dis 1995; 172(3): 706-12.
51. Stone L, Olinky R, Huppert A. Seasonal dynamics of recurrentepidemics. Nature 2007; 446(7135): 533-6.
52. Kilgore PE, Kruszon-Moran D, Seward JF, et al. Varicella inAmericans from NHANES III: Implications for control throughroutine immunization. J Med Virol 2003; 70(Suppl 1): S111-8.
53. Salomon JB, Gordon JE, Scrimshaw NS. Studies of diarrhealdisease in Central America. X. Associated chickenpox, diarrhea andkwashiorkor in a highland Guatemalan village. Am J Tropical MedHygiene 1966; 15(6): 997-1002.
54. Liyanage NP, Fernando S, Malavige GN, et al. Seroprevalence ofvaricella zoster virus infections in Colombo district, Sri Lanka. IndJ Medical Sci 2007; 61(3): 128-34.
55. WHO. Epidemiology of chickenpox. Weekly EpidemiologicalRecord 1992; 16: 118-9.
56. Garnett GP, Cox MJ, Bundy DA, Didier JM, St Catharine J. Theage of infection with varicella-zoster virus in St Lucia, West Indies.Epidemiol Infect 1993; 110(2): 361-72.
57. Miller ER, Kelly HA. Varicella infection--evidence for peakactivity in summer months. J Infect 2008; 56(5): 360-5.
58. Maretic Z, Cooray MP. Comparisons between Chickenpox in aTropical and a European Country. J Tropical Med Hygiene 1963;66: 311-5.
59. White E. Chickenpox in Kerala. Ind J Public Health 1978; 22(1):141-51.
60. Venkitaraman AR, John TJ. The epidemiology of varicella in staffand students of a hospital in the tropics. Int J Epidemiol 1984;13(4): 502-5.
61. Mandal BK, Mukherjee PP, Murphy C, Mukherjee R, Naik T.Adult susceptibility to varicella in the tropics is a rural phenomenondue to the lack of previous exposure. J Infect Dis 1998; 178(Suppl1): S52-4.
62. Lolekha S, Tanthiphabha W, Sornchai P, et al. Effect of climaticfactors and population density on varicella zoster virusepidemiology within a tropical country. Am J Trop Med Hyg 2001;64(3-4): 131-6.
63. Chang CK, Tan HF, Tseng HF, Lin CC. Analysis of factorsassociated with varicella-zoster virus susceptibility among children0-12 years old in Taiwan. Med Mal Infect 2007; 37(4): 222-8.
64. Dayan GH, Panero MS, Debbag R, et al. Varicella seroprevalenceand molecular epidemiology of varicella-zoster virus in Argentina,2002. J Clin Microbiol 2004; 42(12): 5698-704.
65. Kanra G, Tezcan S, Badur S. Varicella seroprevalence in a randomsample of the Turkish population. Vaccine 2002; 20(9-10): 1425-8.
66. O'Grady KA, Merianos A, Patel M, Gilbert L. High seroprevalenceof antibodies to varicella zoster virus in adult women in a tropicalclimate. Trop Med Int Health 2000; 5(10): 732-6.
67. Bang F. Epidemiological interference. Int J Epidemiol 1975; 4(4):337-42.
68. Muir WB, Nichols R, Breuer J. Phylogenetic analysis of varicella-zoster virus: Evidence of intercontinental spread of genotypes andrecombination. J Virol 2002; 76(4): 1971-9.
69. Barrett-Muir W, Scott FT, Aaby P, et al. Genetic variation ofvaricella-zoster virus: Evidence for geographical separation ofstrains. J Med Virol 2003; 70(Suppl 1): S42-7.
70. Quinlivan M, Hawrami K, Barrett-Muir W, et al. The molecularepidemiology of varicella-zoster virus: Evidence for geographicsegregation. J Infect Dis 2002; 186(7): 888-94.
71. Loparev VN, Gonzalez A, Deleon-Carnes M, et al. Globalidentification of three major genotypes of varicella-zoster virus:Longitudinal clustering and strategies for genotyping. J Virol 2004;78(15): 8349-58.
72. Loparev VN, Rubtcova EN, Bostik V, et al. Identification of fivemajor and two minor genotypes of varicella-zoster virus strains: Apractical two-amplicon approach used to genotype clinical isolatesin Australia and New Zealand. J Virol 2007; 81(23): 12758-65.
73. Wagenaar TR, Chow VT, Buranathai C, Thawatsupha P, Grose C.The out of Africa model of varicella-zoster virus evolution: Singlenucleotide polymorphisms and private alleles distinguish Asianclades from European/North American clades. Vaccine 2003;21(11-12): 1072-81.
74. Cameron JC, Allan G, Johnston F, Finn A, Heath PT, Booy R.Severe complications of chickenpox in hospitalised children in theUK and Ireland. Arch Dis Childhood 2007; 92(12): 1062-6.
75. Santos RA, Hatfield CC, Cole NL, et al. Varicella-zoster virus gEescape mutant VZV-MSP exhibits an accelerated cell-to-cell spreadphenotype in both infected cell cultures and SCID-hu mice.Virology 2000; 275(2): 306-17.
76. Tipples GA, Stephens GM, Sherlock C, et al. New variant ofvaricella-zoster virus. Emerg Infect Dis 2002; 8(12): 1504-5.
77. Natoli S, Ciotti M, Paba P, et al. A novel mutation of varicella-zoster virus associated to fatal hepatitis. J Clin Virol 2006; 37(1):72-4.
78. Wirgart BZ, Estrada V, Jackson W, Linde A, Grose C. A novelvaricella-zoster virus gE mutation discovered in two Swedishisolates. J Clin Virol 2006; 37(2): 134-6.
79. Taha Y, Hemmatpor S, Nichols R, et al. HLA class Ipolymorphisms and susceptibility to zoster and post herpeticneuralgia. ICAAC. Washington DC 2005.
80. Iyun F. Chickenpox occurrence in Ibadan city: A geographicperspective. Geogr Med 1984; 14: 73-96.
81. Wu PY, Li YC, Wu HD. Risk factors for chickenpox incidence inTaiwan from a large-scale computerized database. Int J Dermatol2007; 46(4): 362-6.
82. Richard VS, John TJ, Kenneth J, Ramaprabha P, Kuruvilla PJ,Chandy GM. Should health care workers in the tropics isimmunized against varicella? J Hosp Infect 2001; 47(3): 243-5.
83. Reis AD, Pannuti CS, de Souza VA. [Prevalence of varicella-zostervirus antibodies in young adults from different Brazilian climaticregions]. Rev Soc Bras Med Trop 2003; 36(3): 317-20.
84. Kokaze A, Yoshida M, Sekine Y, et al. The magnitude of variationin temperature within a year has an effect on the seasonal variationsof chickenpox incidence in Japan. Epidemiol Infect 2001; 126(2):269-77.
85. Seward JF, Watson BM, Peterson CL, Mascola L, Pelosi JW,Zhang JX, et al. Varicella disease after introduction of varicellavaccine in the United States, 1995-2000. JAMA 2002; 287(5): 606-11.
86. Lowe GL, Salmon RL, Thomas DR, Evans MR. Decliningincidence of chickenpox in the absence of universal childhoodimmunisation. Arch Dis Childhood 2004; 89(10): 966-9.
87. Brisson M, Edmunds WJ. Epidemiology of varicella-zoster virus inEngland and Wales. J Med Virol 2003; 70(Suppl 1): S9-14.
88. Boelle PY, Hanslik T. Varicella in non-immune persons: Incidence,hospitalization and mortality rates. Epidemiol Infect 2002; 129(3):599-606.
89. De Melker H, Berbers G, Hahne S, et al. The epidemiology ofvaricella and herpes zoster in The Netherlands: Implications forvaricella zoster virus vaccination. Vaccine 2006; 24(18): 3946-52.
90. Arama V, Rafila A, Streinu-Cercel A, et al. Varicella in Romania:epidemiological trends, 1986-2004. Euro Surveill 2005; 10(8):E050811 6.
91. Pinot de Moira A, Nardone A. Varicella zoster virus vaccinationpolicies and surveillance strategies in Europe. Euro Surveill 2005;10(1): 43-5.
92. Ciofi degli Atti ML, Rota MC, Mandolini D, et al. Assessment ofvaricella underreporting in Italy. Epidemiol Infect 2002; 128(3):479-84.
93. Rasch G, Hellebrand W. Germany adds varicella vaccine to thenational vaccination program. Euro Surveill 2004; 8(31).
94. Reuss A, Kappelmayer L, Eckmanns T, Poggensee G. Usingstatutory health insurance data to determine varicella vaccinationcoverage for 2-year children born in 2004 in Germany. 2008 [cited14/2/09]; Powerpoint presentation - web based]. Available from:http://www.2008.escaide.eu/site/download.cfm?SAVE=17897&LG=1.
95. Guess HA, Broughton DD, Melton LJ, 3rd, Kurland LT.Population-based studies of varicella complications. Pediatrics1986; 78(4 Pt 2): 723-7.
96. Wharton M. The epidemiology of varicella-zoster virus infections.Infect Dis Clin North Am 1996; 10(3): 571-81.
97. Yawn BP, Yawn RA, Lydick E. Community impact of childhoodvaricella infections. J Pediatr 1997; 130(5): 759-65.
98. Finger R, Hughes JP, Meade BJ, Pelletier AR, Palmer CT. Age-specific incidence of chickenpox. Public Health Rep 1994; 109(6):750-5.
99. Ofsted. Office of standards and education. Registered childcareproviders and places in England, 31 March 2003. Office ofStandards and Education (Ofsted) publication Pub: 24/6/03; 2003.
100. Thiry N, Beutels P, Shkedy Z, et al. The seroepidemiology ofprimary varicella-zoster virus infection in Flanders (Belgium). Eur JPediatr 2002; 161(11): 588-93.
101. Fairley CK, Miller E. Varicella-zoster virus epidemiology-achanging scene? J Infect Dis 1996; 174(Suppl 3): S314-9.
102. Coplan P, Black S, Rojas C, et al. Incidence and hospitalizationrates of varicella and herpes zoster before varicella vaccineintroduction: A baseline assessment of the shifting epidemiology ofvaricella disease. Pediatr Infect Dis J 2001; 20(7): 641-5.
103. Gray GC, Palinkas LA, Kelley PW. Increasing incidence ofvaricella hospitalizations in United States Army and Navypersonnel: Are today's teenagers more susceptible? Should recruitsbe vaccinated? Pediatrics 1990; 86(6): 867-73.
104. Herrin VE, Gray GC. Decreasing rates of hospitalization forvaricella among young adults. J Infect Dis 1996; 174(4): 835-8.
105. Nardone A, de Ory F, Carton M, et al. The comparative sero-epidemiology of varicella zoster virus in 11 countries in theEuropean region. Vaccine 2007; 25(45): 7866-72.
106. Vyse AJ, Gay NJ, Hesketh LM, Morgan-Capner P, Miller E.Seroprevalence of antibody to varicella zoster virus in England andWales in children and young adults. Epidemiol Infect 2004; 132(6):1129-34.
107. Kudesia G, Partridge S, Farrington CP, Soltanpoor N. Changes inage related seroprevalence of antibody to varicella zoster virus:Impact on vaccine strategy. J Clin Pathol 2002; 55(2): 154-5.
108. Salleras L, Dominguez A, Plans P, et al. Seroprevalence of varicellazoster virus infection in child and adult population of Catalonia(Spain). Med Microbiol Immunol 2007.
109. Gabutti G, Penna C, Rossi M, et al. The seroepidemiology ofvaricella in Italy. Epidemiol Infect 2001; 126(3): 433-40.
110. Khoshnood B, Debruyne M, Lancon F, et al. Seroprevalence ofvaricella in the French population. Pediatr Infect Dis J 2006; 25(1):41-4.
111. Saadatian-Elahi M, Mekki Y, Del Signore C, et al. Seroprevalenceof varicella antibodies among pregnant women in Lyon-France. EurJ Epidemiol 2007; 22(6): 405-9.
112. Wutzler P, Farber I, Wagenpfeil S, Bisanz H, Tischer A.Seroprevalence of varicella-zoster virus in the German population.Vaccine 2001; 20(1-2) 121-4.
113. Aebi C, Fischer K, Gorgievski M, Matter L, Muhlemann K. Age-specific seroprevalence to varicella-zoster virus: Study in Swisschildren and analysis of European data. Vaccine 2001; 19(23-24):3097-103.
114. Heininger U, Braun-Fahrlander C, Desgrandchamps D, et al.Seroprevalence of varicella-zoster virus immunoglobulin Gantibodies in Swiss adolescents and risk factor analysis forseronegativity. Pediatr Infect Dis J 2001; 20(8): 775-8.
115. Svahn A, Berggren J, Parke A, Storsaeter J, Thorstensson R, LindeA. Changes in seroprevalence to four herpesviruses over 30 years inSwedish children aged 9-12 years. J Clin Virol 2006; 37(2): 118-23.
116. Parment PA, Svahn A, Ruden U, et al. Immunogenicity andreactogenicity of a single dose of live attenuated varicella vaccineand a booster dose of measles-mumps-rubella vaccine givenconcomitantly at 12 years of age. Scand J Infect Dis 2003; 35(10):736-42.
117. Aarnisalo J, Ilonen J, Vainionpaa R, Volanen I, Kaitosaari T, SimellO. Development of antibodies against cytomegalovirus, varicella-zoster virus and herpes simplex virus in Finland during the firsteight years of life: a prospective study. Scand J Infect Dis 2003;35(10): 750-3.
118. Mossong J, Putz L, Schneider F. Seroprevalence and force ofinfection of varicella-zoster virus in Luxembourg. Epidemiol Infect2004; 132(6): 1121-7.
119. Kelley PW, Petruccelli BP, Stehr-Green P, Erickson RL, Mason CJ.The susceptibility of young adult Americans to vaccine-preventableinfections. A national serosurvey of US Army recruits. JAMA1991; 266(19): 2724-9.
120. Struewing JP, Hyams KC, Tueller JE, Gray GC. The risk ofmeasles, mumps, and varicella among young adults: a serosurvey ofUS Navy and Marine Corps recruits. Am J Public Health 1993;83(12): 1717-20.
121. Welgama U, Wickramasinghe C, Perera J. Varicella-zoster virusinfection in the Infectious Diseases Hospital, Sri Lanka. CeylonMed J 2003; 48(4): 119-21.
122. Venkitaraman AR, Seigneurin JM, Lenoir GM, John TJ. Infectionsdue to the human herpesviruses in southern India: Aseroepidemiological survey. Int J Epidemiol 1986; 15(4): 561-6.
123. Lokeshwar MR, Agrawal A, Subbarao SD, et al. Age relatedseroprevalence of antibodies to varicella in India. Ind Pediatr 2000;37(7): 714-9.
124. Akram DS, Qureshi H, Mahmud A, et al. Seroepidemiology ofvaricella-zoster in Pakistan. The Southeast Asian J Trop Med PublicHealth 2000; 31(4): 646-9.
125. Saha SK, Darmstadt GL, Hanif M, Khan R. Seroepidemiology ofvaricella-zoster virus in Bangladesh. Ann Tropical Paediatr 2002;22(4): 341-5.
126. Talukder YS, Kafatos G, Pinot de Moira A, et al. Theseroepidemiology of varicella zoster virus among pregnantBangladeshi and white British women in the London Borough ofTower Hamlets, UK. Epidemiol Infect 2007; 135(8): 1344-53.
127. Kjersem H, Jepsen S. Varicella among immigrants from the tropics,a health problem. Scand J Soc Med 1990; 18(3): 171-4.
128. Bhattarakoso l P, Chantarabul S, Pittayathikhun K, Mung-mee V,Punnarugsa V. Prevalence of anti-varicella zoster IgG antibody inundergraduate students. Asian Pac J Allergy Immunol 1996; 14(2):129-31.
129. Migasena S, Simasathien S, Desakorn V, et al. Seroprevalence ofVaricella-Zoster Virus Antibody in Thailand. Int J Infect Dis 1997;2(1): 26-30.
130. Kowitdamrong E, Pancharoen C, Thammaborvorn R, Bhattarakoso IP. The prevalence of varicella-zoster virus infection in normalhealthy individuals aged above 6 months. J Medical Association ofThailand = Chotmaihet Thangphaet 2005; 88(Suppl 4): S7-11.
131. Ooi PL, Goh KT, Doraisingham S, Ling AE. Prevalence ofvaricella-zoster virus infection in Singapore. Southeast Asian JTrop Med Public Health 1992; 23(1): 22-5.
132. Kang CI, Choi CM, Park TS, Lee DJ, Oh MD, Choe KW. Incidenceof herpes zoster and seroprevalence of varicella-zoster virus inyoung adults of South Korea. Int J Infect Dis 2008; 12(3): 245-7.
133. Jezek Z, Hardjotanojo W, Rangaraj AG. Facial scarring aftervaricella. A comparison with variola major and variola minor. Am JEpidemiol 1981; 114(6): 798-803.
134. Sixl W, Schneeweiss WD, Withalm H, Schuhmann G, Rosegger H.Serological testing of human blood samples for infectious diseasesin the Abeokuta and the Minna Hospitals/Nigeria. J Hyg EpidemiolMicrobiol Immunol 1987; 31(4 Suppl): 490-2.
135. Nysse LJ, Pinsky NA, Bratberg JP, et al. Seroprevalence ofantibody to varicella among Somali refugees. Mayo Clinic Proc2007; 82(2): 175-80.
136. Lerman Y, Chodick G, Tepper S, Livni G, Ashkenazi S.Seroepidemiology of varicella-zoster virus antibodies amonghealth-care workers and day-care-centre workers. Epidemiol Infect2004; 132(6): 1135-8.
137. Almuneef M, Memish ZA, Balkhy HH, Alotaibi B, Helmy M.Chickenpox complications in Saudi Arabia: Is it time for routinevaricella vaccination? Int J Infect Dis 2006; 10(2): 156-61.
138. Chodick G, Ashkenazi S, Livni G, Lerman Y. Cost-effectiveness ofvaricella vaccination of healthcare workers. Vaccine 2005; 23(43):5064-72.
139. Musharrafieh UM, Nuwayhid IA, Hamadeh GN, Steitieh SW, BizriAR. Immunity to chickenpox among school adolescents in Lebanonand options for vaccination. Epidemiol Infect 2002; 129(3): 607-15.
140. Kurugol Z, Koturoglu G, Aksit S, Ozacar T. Varicellaseroprevalence in Turkish population in Cyprus. Acta Paediatr2007; 96(6): 861-3.
141. Yu AL, Costa JM, Amaku M, et al. Three year seroepidemiologicalstudy of varicella-zoster virus in Sao Paulo, Brazil. Revista doInstituto de Medicina Tropical de Sao Paulo 2000; 42(3): 125-8.
142. O. A seroepidemiologic survey of theprevalence of varicella-zoster virus in the pediatric population intwo university hospitals in Brazil. Int J Dermatol 2003; 42(3): 193-6.
143. Bartoloni A, Bartalesi F, Roselli M, et al. Seroprevalence ofvaricella zoster and rubella antibodies among rural populations ofthe Chaco region, south-eastern Bolivia. Trop Med Int Health 2002;7(6): 512-7.
144. Alvarez y, Munoz MT, Torres J, et al. Susceptibility to varicella-zoster infection in individuals 1 to 29 years of age in Mexico. ArchMed Res 1999; 30(1): 60-3.
145. Gidding HF, MacIntyre CR, Burgess MA, Gilbert GL. Theseroepidemiology and transmission dynamics of varicella inAustralia. Epidemiol Infect 2003; 131(3): 1085-9.
146. Macartney KK, Burgess MA. Varicella vaccination in Australia andNew Zealand. J Infect Dis 2008; 197(Suppl 2): S191-5.
147. MacIntyre CR, Chu CP, Burgess MA. Use of hospitalization andpharmaceutical prescribing data to compare the prevaccinationburden of varicella and herpes zoster in Australia. Epidemiol Infect2003; 131(1): 675-82.
148. Bonsignori F, Chiappini E, Frenos S, Peraldo M, Galli L, deMartino M. Hospitalization rates for complicated anduncomplicated chickenpox in a poorly vaccined pediatricpopulation. Infection 2007; 35(6): 444-50.
149. Bonhoeffer J, Baer G, Muehleisen B, et al. Prospective surveillanceof hospitalisations associated with varicella-zoster virus infectionsin children and adolescents. Eur J Pediatr 2005; 164(6): 366-70.
150. Ziebold C, von Kries R, Lang R, Weigl J, Schmitt HJ. Severecomplications of varicella in previously healthy children inGermany: a 1-year survey. Pediatrics 2001; 108(5): E79.
151. Bovill B, Bannister B. Review of 26 years' hospital admissions forchickenpox in North London. J Infection 1998; 36(Suppl 1): 17-23.
152. McKendrick MW, Lau J, Alston S, Bremner J. VZV infection inpregnancy: A retrospective review over 5 years in Sheffield anddiscussion on the potential utilisation of varicella vaccine inprevention. J Infect 2007; 55(1): 64-7.
153. Grimprel E, Levy C, de La Rocque F, et al. Paediatric varicellahospitalisations in France: A nationwide survey. Clin MicrobiolInfect 2007; 13(5): 546-9.
154. Dubos F, Grandbastien B, Hue V, Martinot A. Epidemiology ofhospital admissions for paediatric varicella infections: A one-yearprospective survey in the pre-vaccine era. Epidemiol Infect 2007;135(1): 131-8.
155. Mallet E, Maitre M, Delalande-Dutilleul L, Marguet C, MouterdeO. [Evaluation of varicella complications through a retrospectivehospital survey in a paediatric center over 16 years in France]. ArchPediatr 2004; 11(9): 1145-51.
156. Gil A, Oyaguez I, Carrasco P, Gonzalez A. Epidemiology ofprimary varicella hospitalizations in Spain. Vaccine 2001; 20(3-4):295-8.
157. Frenos S, Galli L, Chiappini E, de Martino M. An increasingincidence of chickenpox central nervous system complications in children: What's happening in Tuscany? J Clin Virol 2007; 38(4):358-61.
158. Marchetto S, de Benedictis FM, de Martino M, et al. Epidemiologyof hospital admissions for chickenpox in children: An Italianmulticentre study in the pre-vaccine era. Acta Paediatr 2007;96(10): 1490-3.
159. Jaeggi A, Zurbruegg RP, Aebi C. Complications of varicella in adefined central European population. Arch Dis Childhood 1998;79(6): 472-7.
160. Liese JG, Grote V, Rosenfeld E, Fischer R, Belohradsky BH, vKries R. The burden of varicella complications before theintroduction of routine varicella vaccination in Germany. PediatrInfect Dis J 2008; 27(2): 119-24.
161. Nilsson A, Ortqvist A. Severe varicella pneumonia in adults inStockholm County 1980-1989. Scand J Infect Dis 1996; 28(2): 121-3.
162. Mohsen AH, McKendrick M. Varicella pneumonia in adults. EurRespir J 2003; 21(5): 886-91.
163. Lin F, Hadler JL. Epidemiology of primary varicella and herpeszoster hospitalizations: The pre-varicella vaccine era. J Infect Dis2000; 181(6): 1897-905.
164. Rivest P, Bedard L, Valiquette L, et al. Severe complicationsassociated with varicella: Province of Quebec, April 1994 to March1996. Can J Infect Dis 2001; 12(1): 21-6.
165. Jeena PM, Wesley AG, Coovadia HM. Infectious diseases at thepaediatric isolation units of Clairwood and King Edward VIIIHospitals, Durban. Trends in admission and mortality rates (1985-1996) and the early impact of HIV (1994-1996). S Afr Med J. 1998;88(7): 867-72.
166. Chuang YY, Huang a, Chang LY, Chiu CH, Lin TY.Complications of varicella requiring hospitalisation before and afterthe introduction of varicella vaccine in a children's hospital inTaiwan. Eur J Pediatr 2003; 162(2): 112-113.
167. Maharshak N, Somekh E. Hospitalization for varicella in central Israel. Acta Paediatr 1999; 88(11): 1279-83.
168. Carapetis JR, Russell DM, Curtis N. The burden and cost of hospitalised varicella and zoster in Australian children. Vaccine 2004; 23(6): 755-61.
169. Grote V, von Kries R, Springer W, Hammersen G, Kreth HW,Liese J. Varicella-related deaths in children and adolescents--Germany 2003-2004. Acta Paediatr 2008; 97(2): 187-92.
170. Rawson H, Crampin A, Noah N. Deaths from chickenpox inEngland and Wales 1995-7: Analysis of routine mortality data. BMJClin Res Ed 2001; 323(7321): 1091-3.
171. Meyer PA, Seward JF, Jumaan AO, Wharton M. Varicellamortality: Trends before vaccine licensure in the United States,1970-1994. J Infect Dis 2000; 182(2): 383-90.
172. CMAJ. Chickenpox in Canada, 1924-87. CMAJ 1988; 138(2): 133-4.
173. Marin M, Watson TL, Chaves SS, et al. Varicella among adults:data from an active surveillance project, 1995-2005. J Infect Dis2008; 197(Suppl 2): S94-100.
174. CDC. Prevention of varicella: recommendations of the advisorycommittee on immunization practices [ACIP]. MMWR RecommRep 1996; 45: RR-11.
175. CDC. Licensure of varicella virus vaccine, live. MMWR MorbMortal Wkly Rep 1995; 44(13): 264.
176. Seward JF, Watson BM, Peterson CL, et al. Varicella disease afterintroduction of varicella vaccine in the United States, 1995-2000.JAMA 2002; 287(5): 606-11.
177. Guris D, Jumaan AO, Mascola L, et al. Changing varicellaepidemiology in active surveillance sites-United States, 1995-2005. J Infect Dis 2008; 197(Suppl 2): S71-5.
178. Civen R, Lopez AS, Zhang J, et al. Varicella outbreakepidemiology in an active surveillance site, 1995-2005. J Infect Dis2008; 197(Suppl 2): S114-9.
179. Davis MM, Patel MS, Gebremariam A. Decline in varicella-relatedhospitalizations and expenditures for children and adults afterintroduction of varicella vaccine in the United States. Pediatrics2004; 114(3): 786-92.
180. Reynolds MA, Watson BM, Plott-Adams KK, et al. Epidemiologyof varicella hospitalizations in the United States, 1995-2005. JInfect Dis 2008; 197(Suppl 2): S120-6.
181. Nguyen HQ, Jumaan AO, Seward JF. Decline in mortality due tovaricella after implementation of varicella vaccination in the UnitedStates. New Eng J Med 2005; 352(5): 450-8.
182. Kuter BJ, Ngai A, Patterson CM, et al. Safety, tolerability, andimmunogenicity of two regimens of Oka/Merck varicella vaccine(Varivax) in healthy adolescents and adults. Oka/Merck varicellavaccine study group. Vaccine 1995; 13(11): 967-72.
183. Seward JF, Marin M, Vazquez M. Varicella vaccine effectivenessin the US vaccination program: A review. J Infect Dis 2008;197(Suppl 2): S82-9.
184. Chaves SS, Haber P, Walton K, et al. Safety of varicella vaccineafter licensure in the United States: Experience from reports to thevaccine adverse event reporting system, 1995-2005. J Infect Dis 2008; 197(Suppl 2): S170-7.
185. Clements DA, Moreira SP, Coplan PM, Bland CL, Walter EB.Postlicensure study of varicella vaccine effectiveness in a day-caresetting. Pediatr Infect Dis J 1999; 18(12): 1047-50.
186. Vazquez M, LaRussa PS, Gershon AA, et al. Effectiveness overtime of varicella vaccine. JAMA 2004; 291(7): 851-5.
187. Vazquez M, LaRussa PS, Gershon AA, Steinberg SP, FreudigmanK, Shapiro ED. The effectiveness of the varicella vaccine in clinicalpractice. New Eng J Med 2001; 344(13): 955-60.
188. Dworkin MS, Jennings CE, Roth-Thomas J, Lang JE, StukenbergC, Lumpkin JR. An outbreak of varicella among children attendingpreschool and elementary school in Illinois. Clin Infect Dis 2002;35(1): 102-4.
189. Marin M, Nguyen HQ, Keen J, et al. Importance of catch-upvaccination: Experience from a varicella outbreak, Maine, 2002-2003. Pediatrics 2005; 115(4): 900-5.
190. Lopez AS, Lett SM, Yih WK, Northrup J, Jumaan AO, Seward JF.Increasing evidence of immunity to varicella among children inMassachusetts, 1999-2003. Am J Prev Med 2006; 30(3): 232-6.
191. Varicella outbreak among vaccinated children--Nebraska,2004. MMWR Recomm Rep 2006; 55(27): 749-52.
192. Parker AA, Reynolds MA, Leung J, et al. Challenges toimplementing second-dose varicella vaccination during an outbreakin the absence of a routine 2-dose vaccination requirement-Maine,2006. J Infect Dis 2008; 197(Suppl 2): S101-7.
193. Verstraeten T, Jumaan AO, Mullooly JP, et al. A retrospectivecohort study of the association of varicella vaccine failure withasthma, steroid use, age at vaccination, and measles-mumps-rubellavaccination. Pediatrics 2003; 112(2): e98-103.
194. Black S, Ray P, Shinefield H, Saddier P, Nikas A. Lack ofassociation between age at varicella vaccination and risk ofbreakthrough varicella, within the Northern California KaiserPermanente medical care program. J Infect Dis 2008; 197(Suppl 2):S139-42.
195. Chaves SS, Gargiullo P, Zhang JX, et al. Loss of vaccine-inducedimmunity to varicella over time. New Eng J Med 2007; 356(11):1121-9.
196. Marin M, Guris D, Chaves SS, Schmid S, Seward JF. Prevention ofvaricella: recommendations of the advisory committee onimmunization practices (ACIP). MMWR Recomm Rep 2007;56(RR-4): 1-40.
197. Centers for diseases control. update: Recommendations from theAdvisory Committee on Immunization Practices (ACIP) regardingadministration of combination MMRV vaccine. MMWR MorbMortal Wkly Rep 2008; 57(10): 258-60.
198. Terada K, Hiraga Y, Kawano S, Kataoka N. [Incidence of herpeszoster in pediatricians and history of reexposure to varicella-zostervirus in patients with herpes zoster]. Kansenshogaku Zasshi 1995;69(8): 908-12.
199. Gershon AA, LaRussa P, Steinberg S, Mervish N, Lo SH, Meier P.The protective effect of immunologic boosting against zoster: ananalysis in leukemic children who were vaccinated againstchickenpox. J Infect Dis 1996; 173(2): 450-3.
200. Brisson M, Gay NJ, Edmunds WJ, Andrews NJ. Exposure tovaricella boosts immunity to herpes-zoster: Implications for massvaccination against chickenpox. Vaccine 2002; 20(19-20): 2500-7.
201. Thomas SL, Wheeler JG, Hall AJ. Contacts with varicella or withchildren and protection against herpes zoster in adults: A case-control study. Lancet 2002; 360(9334): 678-82.
202. Hardy I, Gershon AA, Steinberg SP, LaRussa P. The incidence ofzoster after immunization with live attenuated varicella vaccine. Astudy in children with leukemia. Varicella vaccine collaborativestudy group. New Eng J Med 1991; 325(22): 1545-50.
203. Jumaan AO, Yu O, Jackson LA, Bohlke K, Galil K, Seward JF.Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002. JInfect Dis 2005; 191(12): 2002-7.
204. Mullooly JP, Riedlinger K, Chun C, Weinmann S, Houston H.Incidence of herpes zoster, 1997-2002. Epidemiol Infect 2005;133(2): 245-53.
205. Yih WK, Brooks DR, Lett SM, et al. The incidence of varicella andherpes zoster in Massachusetts as measured by the Behavioral RiskFactor Surveillance System (BRFSS) during a period of increasingvaricella vaccine coverage, 1998-2003. BMC Public Health 2005;5(1): 68.
206. Wreghitt TG, Whipp PJ, Bagnall J. Transmission of chickenpox totwo intensive care unit nurses from a liver transplant patient withzoster. J Hosp Infect 1992; 20(2): 125-6.
207. Hyams PJ, Stuewe MC, Heitzer V. Herpes zoster causing varicella(chickenpox) in hospital employees: Cost of a casual attitude. Am JInfect Control 1984; 12(1): 2-5.
208. Cooper M. Post-herpetic neuralgia. Lancet 1987; 2(8562): 800.
209. Scott FT, Johnson RW, Leedham-Green M, Davies E, EdmundsWJ, Breuer J. The burden of herpes zoster: A prospectivepopulation based study. Vaccine 2006; 24(9): 1308-14.
210. Thomas SL, Hall AJ. What does epidemiology tell us about riskfactors for herpes zoster? Lancet Infect Dis 2004; 4(1): 26-33.
211. Zak-Prelich M, Borkowski JL, Alexander F, Norval M. The role ofsolar ultraviolet irradiation in zoster. Epidemiol Infect 2002;129(3): 593-7.
212. Gallerani M, Manfredini R. Seasonal variation in herpes zosterinfection. Br J Dermatol 2000; 142(3): 588-9.
213. Berger R, Florent G, Just M. Decrease of the lymphoproliferativeresponse to varicella-zoster virus antigen in the aged. Infection andImmunity 1981; 32(1): 24-7.
214. Berger R, Luescher D, Just M. Enhancement of varicella-zoster-specific immune responses in the elderly by boosting with varicellavaccine. J Infect Dis 1984; 149(4): 647.
215. Levin MJ, Smith JG, Kaufhold RM, et al. Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasingage and boosting with a high-dose VZV vaccine. J Infect Dis 2003;188(9): 1336-44.
216. Schmader K, George LK, Burchett BM, Pieper CF, Hamilton JD. Racial differences in the occurrence of herpes zoster. J Infect Dis 1995; 171(3): 701-4.
217. Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS population-based study of the incidence and complication rates ofherpes zoster before zoster vaccine introduction. Mayo Clin Proc 2007; 82(11): 1341-9.
218. Scholl S, Hocke M, Hoffken K, Sayer HG. Acute abdomen byvaricella zoster virus induced gastritis after autologous peripheralblood stem cell transplantation in a patient with non-Hodgkin'slymphoma. Acta Haematol 2006; 116(1): 58-61.
219. Tan HH, Goh CL. Viral infections affecting the skin in organtransplant recipients: Epidemiology and current managementstrategies. Am J Clin Dermatol 2006; 7(1): 13-29.
220. Schuchter LM, Wingard JR, Piantadosi S, Burns WH, Santos GW,Saral R. Herpes zoster infection after autologous bone marrowtransplantation. Blood 1989; 74(4): 1424-7.
221. Feld R, Evans WK, DeBoer G. Herpes zoster in patients withcarcinoma of the lung. Am J Med 1982; 73(6): 795-801.
222. Keidan SE, Mainwaring D. Association of herpes zoster withleukemia and lymphoma in children. Clin Pediatr 1965; 4: 13-7.
223. Veenstra J, Krol A, van Praag RM, et al. Herpes zoster,immunological deterioration and disease progression in HIV-1 infection. AIDS (London, England) 1995; 9(10): 1153-8.
224. Gershon AA, Mervish N, LaRussa P, et al. Varicella-zoster virusinfection in children with underlying human immunodeficiencyvirus infection. J Infect Dis 1997; 176(6): 1496-500.
225. Fleming DM, Cross KW, Cobb WA, Chapman RS. Genderdifference in the incidence of shingles. Epidemiol Infect 2004;132(1): 1.
226. Jung BF, Johnson RW, Griffin DR, Dworkin RH. Risk factors forpostherpetic neuralgia in patients with herpes zoster. Neurology 2004; 62(9): 1545-51.
227. Donahue JG, Choo PW, Manson JE, Platt R. The incidence ofherpes zoster. Arch Int Med 1995; 155(15): 1605-9.
228. Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to preventherpes zoster and postherpetic neuralgia in older adults. New Eng JMed 2005; 352(22): 2271-84.
229. Opstelten W, Van Essen GA, Schellevis F, Verheij TJ, Moons KG.Gender as an independent risk factor for herpes zoster: Apopulation-based prospective study. Ann Epidemiol 2006; 16(9):692-5.
230. Schmader K, George LK, Burchett BM, Pieper CF. Racial andpsychosocial risk factors for herpes zoster in the elderly. J InfectDis 1998; 178(Suppl 1): S67-70.
231. Massad MG, Navarro RA, Rubeiz H, et al. Acute postoperativeshingles after thoracic sympathectomy for hyperhidrosis. AnnThoracic Surg 2004; 78(6): 2159-61.
232. Gilden DH, Katz RI. Surgical induction of zoster in a contralateralhomologous dermatomal distribution. Arch Neurol 2003; 60(4):616-7.
233. Andrews TR, Perdikis G, Shack RB. Herpes zoster as a rarecomplication of liposuction. Plast Reconstr Surg 2004; 113(6):1838-40.
234. Selling L. Relationship of trauma and herpes zoster; Report of threecases. Portland Clin Bull 1948; 1(4): 75-82.
235. Tottie M. Trauma and herpes zoster. Acta Derm-Venereol 1951;31(3): 275-7.
236. Thomas SL, Wheeler JG, Hall AJ. Case-control study of the effectof mechanical trauma on the risk of herpes zoster. BMJ Clin Res 2004; 328(7437): 439.
237. Schmader K, Studenski S, MacMillan J, Grufferman S, Cohen HJ.Are stressful life events risk factors for herpes zoster? J Am GeriatrSoc 1990; 38(11): 1188-94.
238. Chapman RS, Cross KW, Fleming DM. The incidence of shinglesand its implications for vaccination policy. Vaccine 2003; 21(19-20): 2541-7.
239. Gauthier A, Breuer J, Carrington D, Martin M, Remy V. Epidemiology and cost of herpes zoster and post-herpetic neuralgiain the United Kingdom. Epidemiol Infect 2008: 1-10.
240. Edmunds WJ, Brisson M, Rose JD. The epidemiology of herpeszoster and potential cost-effectiveness of vaccination in Englandand Wales. Vaccine 2001; 19(23-24): 3076-90.
241. Opstelten W, Mauritz JW, de Wit NJ, van Wijck AJ, Stalman WA,van Essen GA. Herpes zoster and postherpetic neuralgia: Incidenceand risk indicators using a general practice research database. FamPract 2002; 19(5): 471-5.
242. Helgason S, Petursson G, Gudmundsson S, Sigurdsson JA. Prevalence of postherpetic neuralgia after a first episode of herpeszoster: Prospective study with long term follow up. BMJ Clin ResEd 2000; 321(7264): 794-6.
243. Chidiac C, Bruxelle J, Daures JP, et al. Characteristics of patients with herpes zoster on presentation to practitioners in France. Clin Infect Dis 2001; 33(1): 62-9.
244. Czernichow S., Dupuy A, Flahault A, Chosidow O. [Herpes zoster: Incidence study among "sentinel" general practitioners]. Ann Dermatol Venereol 2001; 128(4): 497-501.
245. Ragozzino MW, Melton LJ, 3rd, Kurland LT, Chu CP, Perry HO. Population-based study of herpes zoster and its sequelae. Medicine 1982; 61(5): 310-6.
246. Harpaz R, Ortega-Sanchez IR, Seward JF. Prevention of herpeszoster: Recommendations of the Advisory Committee onImmunization Practices (ACIP). MMWR Recomm Rep 2008;57(RR-5): 1-30; Quiz CE2-4.
247. Park HH, Lee MH. Concurrent reactivation of varicella zoster virusand herpes simplex virus in an immunocompetent child. J KoreanMedical Sci 2004; 19(4): 598-600.
248. Goh CL, Khoo L. A retrospective study of the clinical presentationand outcome of herpes zoster in a tertiary dermatology outpatientreferral clinic. Int J Dermatol 1997; 36(9): 667-72.
249. Araujo LQ, Macintyre CR, Vujacich C. Epidemiology and burdenof herpes zoster and post-herpetic neuralgia in Australia, Asia andSouth America. Herpes 2007; 14(Suppl 2): 40-4.
250. Dworkin RH. Racial differences in herpes zoster and age at onset ofvaricella. J Infect Dis 1996; 174(1): 239-41.
251. Chant KG, Sullivan EA, Burgess MA, et al. Varicella-zoster virusinfection in Australia. Aust N Z J Public Health 1998; 22(4): 413-8.
252. Alp H, Altinkaynak S, Ertekin V, Kilicaslan B, Giiraksin A.Seroepidemiology of varicella-zoster virus infection in acosmopolitan city (Erzurum) in the eastern Turkey. Health policy(Amsterdam, Netherlands) 2005; 72(1): 119-24.
253. Barzaga NG, Florese RH, Bock HL. Reactogenicity andimmunogenicity of a varicella vaccine in healthy seronegative and seropositive subjects. Southeast Asian J Trop Med Public Health2002; 33(2): 259-67.
254. Chi CY, Wang SM, Lin HC, Liu CC. Complications of varicellainfection in children in southern Taiwan. J Microbiol ImmunolInfect 2006; 39(5): 402-7.
255. Kanra G, Tezcan S, Badur S. Varicella seroprevalence in a randomsample of the Turkish population. Vaccine 2002; 20(9-10): 1425-8.
256. Kavaliotis J, Petridou S, Karabaxoglou D. How reliable is thehistory of chickenpox? Varicella serology among children up to 14years of age. Int J Infect Dis 2003; 7(4): 274-7.
257. Kubo T, Rai SK, Nakanishi M, Yamano T. Seroepidemiologicalstudy of herpes viruses in Nepal. Southeast Asian J Trop MedPublic Health 1991; 22(3): 323-25.
258. Malik YA, Baharin R. Prevalence of varicella-zoster virus inMalaysia. Proceedings of the 5th international congress on theimpact of viral diseases in developing countries. Johannesberg,South Africa. Cited in Lee BW. Review of varicella zosterseroepidemiology in India and Southeast Asia. Trop Med Int Health 1998; 3(11): 886-90.
259. Tan HF, Tseng HF, Chang CK, Ke D, Lee-Hsieh J. The incidenceof varicella in southern Taiwan: A life table method estimationamong susceptible population. Vaccine 2004; 22(21-22): 2730-6.
260. Tseng HW, Liu CC, Wang SM, Yang YJ, Huang YS.Complications of varicella in children: Emphasis on skin andcentral nervous system disorders. J Microbiol Immunol Infect 2000;33(4): 248-52.